Literature DB >> 28196023

The More the Better-Lower Rate of Stage Migration and Better Survival in Patients With Retrieval of 20 or More Regional Lymph Nodes in Pancreatic Cancer: A Population-Based Propensity Score Matched and Trend SEER Analysis.

Rene Warschkow1, Bernhard Widmann, Ulrich Beutner, Lukas Marti, Thomas Steffen, Marc Schiesser, Bruno M Schmied.   

Abstract

OBJECTIVE: The aim of this study was to assess the influence of regional lymph node (RLN) retrieval on stage migration and survival in pancreatic cancer.
METHODS: A total of 7685 stage I and II pancreatic cancer patients were identified in the Surveillance, Epidemiology, and End Results database in 2004-2011. The impact of RLN was assessed using Cox regression, propensity score methods, and joinpoint regression.
RESULTS: In 3079 patients, 1 to 10 RLNs were retrieved; in 2799 patients, 11 to 19 RLNs, and in 1807 patients, 20+ RLNs. The rate of node-positive pancreatic cancer increased with the number of retrieved RLN. This trend continued beyond 10 retrieved RLN (P < 0.001). In unadjusted analysis, retrieval of RLN did not influence survival (P = 0.178). When adjusting for significant bias in staging variables (P < 0.001), retrieval of 20+ RLNs compared to 11 to 19 RLNs was associated with an increased survival in node-negative (hazard ratio, 0.78; 95% confidence interval, 0.62-0.98; P = 0.033) and node-positive cancer (hazard ratio, 0.83; 95% confidence interval, 0.74-0.93; P = 0.002).
CONCLUSIONS: This population-based propensity score-adjusted investigation demonstrated that more retrieved RLNs in pancreatic cancer decreases the rate of stage migration and improves the oncological outcome in node-negative and positive cancer. Contradictory results may be explained by a bias in the cancer characteristics for a different extent of RLN retrieval.

Entities:  

Mesh:

Year:  2017        PMID: 28196023     DOI: 10.1097/MPA.0000000000000784

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  14 in total

1.  Prognostic Impact of Lymph Node Excision in T1 and T2 Gallbladder Cancer: a Population-Based and Propensity Score-Matched SEER Analysis.

Authors:  Thomas Steffen; Sabrina M Ebinger; Ignazio Tarantino; Bernhard Widmann
Journal:  J Gastrointest Surg       Date:  2019-03-18       Impact factor: 3.452

2.  Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant Therapy.

Authors:  Ammar A Javed; Ding Ding; Erum Baig; Michael J Wright; Jonathan A Teinor; Daniyal Mansoor; Elizabeth Thompson; Ralph H Hruban; Amol Narang; William R Burns; Richard A Burkhart; Kelly Lafaro; Matthew J Weiss; John L Cameron; Christopher L Wolfgang; Jin He
Journal:  World J Surg       Date:  2022-01-07       Impact factor: 3.352

3.  Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield.

Authors:  Rene Warschkow; Catherine Tsai; Nastassja Köhn; Suna Erdem; Bruno Schmied; Daniel P Nussbaum; Beat Gloor; Sascha A Müller; Dan Blazer; Mathias Worni
Journal:  Langenbecks Arch Surg       Date:  2020-02-10       Impact factor: 3.445

4.  Score for predicting overall survival in pancreatic adenocarcinoma patients with positive lymph nodes after surgery: a novel nomogram-based risk assessment.

Authors:  Liang Jin; Yiping Zou; Shiye Ruan; Hongwei Han; Yuanpeng Zhang; Zhihong Chen; Haosheng Jin; Ning Shi
Journal:  Gland Surg       Date:  2021-02

5.  A Refined Staging Model for Resectable Pancreatic Ductal Adenocarcinoma Incorporating Examined Lymph Nodes, Location of Tumor and Positive Lymph Nodes Ratio.

Authors:  Yunda Song; Zhenxin Chen; Luohai Chen; Chaobin He; Xin Huang; Fangting Duan; Jun Wang; Xiangming Lao; Shengping Li
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

6.  Prognostic significance of the degree of lymphatic vessel invasion in locally advanced, surgically resectable pancreatic head cancer: A single center experience.

Authors:  Kohei Morita; Hisashi Oshiro; Kumiko Mito; Makiko Naka Mieno; Mio Tamba-Sakaguchi; Toshiro Niki; Atsushi Miki; Masaru Koizumi; Yasunaru Sakuma; Toshihide Komatsubara; Naohiro Sata; Noriyoshi Fukushima
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

Review 7.  Optimizing the outcomes of pancreatic cancer surgery.

Authors:  Oliver Strobel; John Neoptolemos; Dirk Jäger; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2019-01       Impact factor: 66.675

8.  Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.

Authors:  Yu-Feng Li; Yu-Cheng Xiang; Qiu-Qiang Zhang; Wei-Lin Wang
Journal:  J Gastrointest Oncol       Date:  2020-08

9.  Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.

Authors:  Huan-Jun Li; Yu-Tong Chen; Shu-Qiang Yuan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

10.  The Number of Negative Lymph Nodes is Positively Associated with Survival in Esophageal Squamous Cell Carcinoma Patients in China.

Authors:  Lan Yu; Xiao-Tao Zhang; Shang-Hui Guan; Yu-Feng Cheng; Lin-Xi Li
Journal:  Open Med (Wars)       Date:  2020-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.